International Elon Musk’s Neuralink Brain-Chip’s Human Trial Begins | All You Need To Know BY Outlook Web Desk
National Maharashtra: Police Seizes Rs 4.82 Lakh Worth Food Items Manufactured Under Fake FSSAI License, Books 4 People BY Outlook Web Desk
International Explained: What Is Artificial Sweetener Aspartame, What Does The WHO Report Say About Link To Cancer? BY Outlook Web Desk
International Explained: US FDA Approves Elon Musk's Neuralink Chips For Human Trials, What Are The Pros And Cons? BY
International US Health Secretary Slams Texas Ruling On Abortion Pills, Calls It 'Not America' BY Outlook Web Desk
National Eye Drop Row: Tamil Nadu Drug Regulator Finds 'No Contamination' After US Links It To Drug-resistant Bacteria BY Outlook Web Desk
Outlook Spotlight Is Friday Plans Legit? Every Pro and Con You Should Know Before Buying BY Spotlight Desk
National Gambia To United States: India Pharma Industry Has Lately Made Headlines For Wrong Reasons BY Outlook Web Desk
National Indian Pharma Company Lupin Recalls Skin Medicine In USA Over Poor Quality BY Outlook Web Desk
National Explained: Why Maharashtra Stopped Johnson & Johnson Baby Powder's Sale, HC Ruling And Other Controversies BY Outlook Web Desk
Business Spotlight Kinetic Smart Watch Reviews - Is Kinetic Pro Watch Scam or Legit? BY Spotlight Desk
National Explained: Johnson & Johnson To Stop Selling Talc Baby Powder, The Talc Controversy, And Alleged Talc-Cancer Link BY Madhur Sharma
Business Spotlight LifeVac Reviews - Does Lifevac Really Work? Is Lifevac Safe? Read This Before You Buy! BY Spotlight Desk
International Covid-19 Vaccination: First Shots For Kids Under 5 Possible By June 21, Says White House BY
Business Alembic Pharmaceuticals Gets USFDA Nod To Market Generic Tablet For Atrial Fibrillation BY Outlook Web Desk
miscellaneous PM Calls Retired Lt Gen Hooda, Assures That His Ailing Sister's Request On New Breast Cancer Drug Will Be Considered BY Outlook Web Desk
National Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children BY Outlook Web Desk
Making A Difference US: 5 To 11-Year-Old Kids May Get Covid-19 Vaccine Soon As FDA Panel Endorses Pfizer Shots BY Associated Press
Making A Difference Pfizer Urges US Govt To Allow Covid-19 Shots For Kids Of 5 To 11 Years Age BY Associated Press
Making A Difference US Approves Booster Dose Of Pfizer's Covid-19 Vaccine For Special Groups BY Associated Press
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
